Our paper describing CHRNA6 expression in extraskeletal myxoid chondrosarcoma is free to access for 50 days:

authors.elsevier.com/a/1ipZI3B8d8%7…

Led by Stanford Pathology resident Ben Dulken, we found increased expression of CHRNA6 in EMC, which is detectable by RNA ISH.

#BSTpath #PathTwitter

In a study using Washington University in St. Louis #HTAN data and #SpatialTranscriptomics , JaiWoong Seo, Greg Charville, Walter Park, et al. characterized #PancreaticCancer cell surface markers and designed a treatment strategy targeting claudin-4 bioRxiv biorxiv.org/content/10.110….

Are you a #BSTpath enthusiast? Do you want to learn more about the latest topics in the field directly from experts from all over?

Then register for the 2025 'Friends of Bone and soft tissue pathology' course: biopticka.cz/bst2025
It's going to be amazing!

#pathtwitter

When I was resident, many pathology researchers were claiming that molecular findings would supplant traditional morphology for classification in #bst tumors. Pathologists would no longer be needed.

#GUpath lunch group:

there’s Grade Group One
&
then there’s 👇🏽One Great Group

I just accepted an awesome paper JClinPath_BMJ on this marker. Must read!

Guest Editor, Gregory W. Charville, MD, PhD, of the latest issue of Surgical Pathology Clinics outlines the latest developments in soft tumor tissue pathology:
#pathology #tumors #softtissue #molecularpathology

surgpath.theclinics.com/article/S1875-…

🚨New Clinical Trial: Stanford University's 'Study of Cryoablation and Nirogacestat for Desmoid Tumor' is recruiting patients with desmoid tumors to test local treatment of cryoablation with the newly FDA approved gamma secretase inhibitor, nirogacestat.
clinicaltrials.gov/study/NCT05949…

New predictive biomarker for gastric cancer - can you identify it based on this pattern of expression? #GIpath #IHCpath #PathTwitter

#PathResidents , these microphotographs are worth a thousand words. What story are they trying to tell you? What is the differential diagnosis?

#GIpath #MedTwitter #Pathology #PathResEssentials #PathX #PathTwitter #path2path #pathmatch2024

24yo male, with peritoneal 'carcinomatosis'

Desmin and CK are positive

What is the most likely molecular alteration?

Poll in next tweet

#PathTwitter

Oh, I do love our April cover JClinPath_BMJ Myxoid liposarcoma in a nutshell. Thank you, Darcy A. Kerr Dartmouth Health Pathology Residency, for these wonderful images. #BSTpath

Dear #GIPath #IHC # #HER2
What score would you give to this difuse poorly cohesive gastric cancer .

Challenging conventional belief, we found that atypical spindle cell/pleomorphic lipomatous tumor (ASPLT) can rarely undergo sarcomatous transformation. Excited to share insights on this phenomenon! #bstpath

modernpathology.org/article/S0893-…

I am thrilled to share the link to our Nature paper that is online today! It shows how matrix viscoelasticity independent of stiffness impacts cancer invasion. Huge thanks to all my co-authors, lab and the GI Division at Stanford and the VA Palo Alto!
rdcu.be/dxrR3

Great multi-institutional #bstpath collaboration - congratulations Raul Perret, MD, MSc 🇦🇷🇨🇵 and Jeffrey Cloutier, MD, PhD!

70s M w/ 1.3cm laryngeal mass near vocal cords. clinically suspicious for neoplasm. Thoughts?

#PathX #PathTwitter

Cool new applications of GRM1 immunohistochemistry to diagnose chondromyxoid fibroma! #BSTpath #IHCpath #Cytopath

Subcutaneous CMF:
pubmed.ncbi.nlm.nih.gov/36810795/

CMF with FGF23 expression mimicking PMT:
pubmed.ncbi.nlm.nih.gov/38303543/

Cytopathology diagnosis of CMF:
pubmed.ncbi.nlm.nih.gov/38281480/